Entrada Quarterly Newsletter Detailing Topline Data From the First Cohort of ELEVATE-44-201 Study and updates on DMD programs

May 7, 2026

On May 7, 2026, Entrada Therapeutics shared a quarterly newsletter detailing topline data from the first cohort of the ELEVATE-44-201 study, as well as updates on each of Entrada’s DMD programs.

To view their newsletter, please click here.

Jett Foundation’s Silver Soirée
Thursday, June 11, 2026 | 5:30PM
Granite Links | Quincy, MA